Henrique Veiga-Fernandes
Champalimaud Foundation
Henrique Veiga-Fernandes studied Veterinary Medicine at Universidade de Lisboa, Portugal and at Università degli Studi di Milano, Italy. In 2002, he obtained a PhD in Immunology from Université René Descartes, Paris, France, before moving to the National Institute for Medical Research, London, UK, as a postdoc. In 2009, he set up his laboratory at Instituto de Medicina Molecular, Portugal, and he served as member of the direction team from 2014 to 2016. Henrique Veiga-Fernandes joined the Champalimaud Centre for the Unknown, Portugal, in 2016 where he is Full investigator. Henrique Veiga-Fernandes made foundational discoveries in the areas of adaptive and innate immunity, pioneering the area of peripheral neuro-immune interactions.
Henrique Veiga-Fernandes integrates the Board of Reviewing Editors of Science AAAS, USA; he is member of the European Molecular Biology Organisation (EMBO) and integrates the EMBO membership committee since 2024. He was made Commander of the Order of Sant’Iago da Espada by Portugal in 2015. He secured several European Research Council (ERC) awards (2007, 2013, 2015, 2017 and 2023). Amongst others, he won the Pfizer Prize for basic Science (2014, 2016, 2020 and 2022), the Allen Distinguished Investigator award in 2018, and the Chan Zuckerberg Initiative (CZI) Award, USA in 2020.
https://www.linkedin.com/in/henrique-veiga-fernandes-a3223234/
Orcid: https://orcid.org/0000-0001-6216-1836
Google scholar: https://scholar.google.com/citations?user=kDZvsIAAAAAJ&hl=en&oi=ao